AIM Therapeutics Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma (NCT01501942) | AIM Therapeutics Inc. | 2012-02-01 |
Track AIM Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.